Clinicians Warn of Fatal Measles Brain Disease - Report - MDSpire

Clinicians Warn of Fatal Measles Brain Disease

  • By

  • Rae Ellen Bichell

  • March 13, 2026

  • 4 min

Share

Clinical Report: Clinicians Warn of Fatal Measles Brain Disease

Overview

Measles can lead to severe complications, including subacute sclerosing panencephalitis (SSPE), a fatal neurological condition. As vaccination rates decline, the incidence of measles and its associated complications, particularly SSPE, is expected to rise.

Background

Measles is a highly contagious viral infection that can cause serious health complications, including SSPE, which typically appears years after initial infection. The risk of developing SSPE is significantly higher in children infected before the age of five. With recent declines in vaccination rates, there is growing concern among healthcare professionals about the resurgence of measles and its long-term effects.

Data Highlights

Remove placeholder text and provide relevant data or state that data is not available.

Key Findings

  • SSPE is a progressive, neurodegenerative condition that can develop 7–10 years after measles infection.
  • The risk of SSPE is approximately 1 in 10,000 cases of measles, increasing to about 1 in 600 for those infected before 12 months of age.
  • Measles complications can include immediate effects like brain swelling and long-term neurological damage.
  • Vaccination with the MMR vaccine reduces the risk of contracting measles from 90% to 3%, thereby decreasing the likelihood of SSPE.
  • Recent data indicate a significant rise in measles cases in the U.S., with over 3,500 cases reported since the start of 2025.
  • SSPE is almost always fatal, and there are currently no effective treatments available.

Clinical Implications

Healthcare providers should prioritize measles vaccination to prevent outbreaks and associated complications like SSPE. Increased awareness and education about the risks of measles and its long-term effects are essential for clinicians, especially in areas with declining vaccination rates.

Conclusion

The resurgence of measles poses a significant public health threat, particularly the risk of SSPE. Preventive measures through vaccination are critical to safeguarding children's health.

References

  1. ADA News, CDC urges health care providers to stay alert for measles cases, 2025 -- CDC urges health care providers to stay alert for measles cases
  2. The ASCO Post, Measles Presents Greater Risks in Children Being Treated for Cancer, 2015 -- Measles Presents Greater Risks in Children Being Treated for Cancer
  3. CDC, Chapter 7: Measles | Manual for the Surveillance of Vaccine-Preventable Diseases, 2025 -- Chapter 7: Measles
  4. PMC, Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment, 2023 -- Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment
  5. The ASCO Post — Measles Presents Greater Risks in Children Being Treated for Cancer
  6. ada news — CDC urges health care providers to stay alert for measles cases
  7. Chapter 7: Measles | Manual for the Surveillance of Vaccine-Preventable Diseases | CDC
  8. Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment - PMC
  9. Subacute Sclerosing Panencephalitis: A Clinical, Radiological, and Outcome Study of 144 Cases - PMC

Original Source(s)

Related Content